Cipla
Dhagash Vora, M.Pharm, MBA, serves as the Associate Director of Business Development & Licensing at Cipla since October 2024. Prior experience includes leading Business Development & Licensing and Strategic Alliances at Dr. Reddy's Laboratories, where Dhagash focused on pharma and biopharma innovation projects, medical devices, and digital therapeutics targeting emerging markets. Previously, Dhagash held multiple roles at Alkem Laboratories Ltd., culminating as Associate General Manager in Corporate Strategy and BD&L, achieving significant product launches and strategic initiatives. Early career experience includes roles in institutional equity research at Axis Capital Ltd. and SBICAP Securities, as well as credit analysis at CRISIL Limited. Educational credentials comprise an Executive Leadership certificate from Babson College, a PGDM in Finance & Strategy, and a Master of Pharmacy degree from the University of Mumbai.
This person is not in the org chart
This person is not in any teams
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.